Citations (33)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Erik De Clercq. (2008) Emerging antiviral drugs. Expert Opinion on Emerging Drugs 13:3, pages 393-416.
Read now
Read now
Jia-Horng Kao. (2008) Diagnosis of hepatitis B virus infection through serological and virological markers. Expert Review of Gastroenterology & Hepatology 2:4, pages 553-562.
Read now
Read now
Stephanos J Hadziyannis & Dimitrios Vassilopoulos. (2008) Telbivudine in the treatment of chronic hepatitis B. Expert Review of Gastroenterology & Hepatology 2:1, pages 13-22.
Read now
Read now
Articles from other publishers (30)
Shivam Chowdhary, Rahul Deka, Kingshuk Panda, Rohit Kumar, Abhishikt David Solomon, Jimli Das, Supriya Kanoujiya, Ashish Kumar Gupta, Somya Sinha, Janne Ruokolainen, Kavindra Kumar Kesari & Piyush Kumar Gupta. (2023) Recent Updates on Viral Oncogenesis: Available Preventive and Therapeutic Entities. Molecular Pharmaceutics 20:8, pages 3698-3740.
Crossref
Crossref
Annapoorna Vadlamani, K. Ravindhranath & B. Sreenivasa Rao. (2022) Detection and Quantification of Two Potential Genotoxic Impurities in Telbivudine Active
Pharmaceutical Ingredient by Targeted Ultra Performance LC-MS/MS Analysis. Asian Journal of Chemistry 34:12, pages 3383-3390.
Crossref
Crossref
A. A. Zenchenko, M. S. Drenichev, I. A. Il’icheva & S. N. Mikhailov. (2021) Antiviral and Antimicrobial Nucleoside Derivatives: Structural Features and Mechanisms of Action. Molecular Biology 55:6, pages 786-812.
Crossref
Crossref
Tuğba DEMİR & Özlem AKPİNAR. (2021) Fitokimyasalların Antiviral EtkileriAntiviral Effects of Phytochemicals. Düzce Üniversitesi Bilim ve Teknoloji Dergisi 9:4, pages 1519-1535.
Crossref
Crossref
Deepthi Ramesh, Balaji Gowrivel Vijayakumar & Tharanikkarasu Kannan. (2021) Advances in Nucleoside and Nucleotide Analogues in Tackling Human Immunodeficiency Virus and Hepatitis Virus Infections. ChemMedChem 16:9, pages 1403-1419.
Crossref
Crossref
Ali KÜÇÜK & Yakup YILDIRIM. (2019) Antiviral İlaçlarAntiviral Drug. Etlik Veteriner Mikrobiyoloji Dergisi 30:1, pages 100-108.
Crossref
Crossref
Simon Weising, Vincente Sterrenberg, Dominique Schols & Chris Meier. (2018)
Synthesis and Antiviral Evaluation of Tri
PPP
ro-AbacavirTP, Tri
PPP
ro-CarbovirTP, and Their 1′,2′-
cis
-Disubstituted Analogues
. ChemMedChem 13:17, pages 1771-1778.
Crossref
Crossref
Latavia Singh, Sunaina Indermun, Mershen Govender, Pradeep Kumar, Lisa du Toit, Yahya Choonara & Viness Pillay. (2018) Drug Delivery Strategies for Antivirals against Hepatitis B Virus. Viruses 10:5, pages 267.
Crossref
Crossref
Weihui Sun, Shangfei Zhao, Lei Ma, Anhua Hao, Bo Zhao, Lin Zhou, Fengzhu Li & Mingquan Song. (2017) Telbivudine treatment started in early and middle pregnancy completely blocks HBV vertical transmission. BMC Gastroenterology 17:1.
Crossref
Crossref
Jia-Horng Kao, Tarik Asselah, Xiao-Guang Dou & Kamal Hamed. (2017) Telbivudine therapy for chronic hepatitis B: A journey to identify super-responders and to optimize treatment using the roadmap model. Journal of Gastroenterology and Hepatology 32:1, pages 73-81.
Crossref
Crossref
Zhangmin Tan, Yuzhu Yin, Jin Zhou, Lingling Wu, Chengfang Xu & Hongying Hou. (2016) Telbivudine treatment of hepatitis B virus-infected pregnant women at different gestational stages for the prevention of mother-to-child transmission. Medicine 95:40, pages e4847.
Crossref
Crossref
G.-R. Han, H.-X. Jiang, X. Yue, Y. Ding, C.-M. Wang, G.-J. Wang & Y.-F. Yang. (2015) Efficacy and safety of telbivudine treatment: an open-label, prospective study in pregnant women for the prevention of perinatal transmission of hepatitis B virus infection. Journal of Viral Hepatitis 22:9, pages 754-762.
Crossref
Crossref
Zhouen Zhang, Hisashi Doi, Hiroko Koyama, Yasuyoshi Watanabe & Masaaki Suzuki. (2014)
Efficient syntheses of [
11
C]zidovudine and its analogs by convenient one-pot palladium(0)-copper(I) co-mediated rapid
C
-[
11
C]methylation
. Journal of Labelled Compounds and Radiopharmaceuticals 57:8, pages 540-549.
Crossref
Crossref
Damodar Janmanchi, Chih Hsiu Lin, Jui-yu Hsieh, Ya-ping Tseng, Tai-an Chen, Hong-jhih Jhuang & Sheau Farn Yeh. (2013) Synthesis and biological evaluation of helioxanthin analogues. Bioorganic & Medicinal Chemistry 21:7, pages 2163-2176.
Crossref
Crossref
Calvin Q. Pan, Guo–Rong Han, Hong–Xiu Jiang, Wei Zhao, Min–Kai Cao, Cui–Min Wang, Xin Yue & Gen–Ju Wang. (2012) Telbivudine Prevents Vertical Transmission From HBeAg-Positive Women With Chronic Hepatitis B. Clinical Gastroenterology and Hepatology 10:5, pages 520-526.
Crossref
Crossref
Guo-Rong Han, Min-Kai Cao, Wei Zhao, Hong-Xiu Jiang, Cui-Min Wang, Shu-Fen Bai, Xin Yue, Gen-Ju Wang, Xun Tang & Zhi-Xun Fang. (2011) A prospective and open-label study for the efficacy and safety of telbivudine in pregnancy for the prevention of perinatal transmission of hepatitis B virus infection. Journal of Hepatology 55:6, pages 1215-1221.
Crossref
Crossref
Donald J. AbrahamAntonin Holý & Erik De Clercq. 2003. Burger's Medicinal Chemistry and Drug Discovery. Burger's Medicinal Chemistry and Drug Discovery
219
256
.
Erik De Clercq, Geoffrey Férir, Suzanne Kaptein & Johan Neyts. (2010) Antiviral Treatment of Chronic Hepatitis B Virus (HBV) Infections. Viruses 2:6, pages 1279-1305.
Crossref
Crossref
Stephanos J. Hadziyannis. (2010) New developments in the treatment of chronic hepatitis B. Arab Journal of Gastroenterology 10:4, pages S7-S9.
Crossref
Crossref
Damodar Janmanchi, Ya Ping Tseng, Kuei-Chen Wang, Ray Ling Huang, Chih Hsiu Lin & Sheau Farn Yeh. (2010) Synthesis and the biological evaluation of arylnaphthalene lignans as anti-hepatitis B virus agents. Bioorganic & Medicinal Chemistry 18:3, pages 1213-1226.
Crossref
Crossref
Saugata Hazra, Elisabetta Sabini, Stephan Ort, Manfred Konrad & Arnon Lavie. (2009) Extending Thymidine Kinase Activity to the Catalytic Repertoire of Human Deoxycytidine Kinase. Biochemistry 48:6, pages 1256-1263.
Crossref
Crossref
E. De Clercq & J. Neyts. 2009. Antiviral Strategies. Antiviral Strategies
53
84
.
R. Morillo Verdugo, A. Madrazo Berenguer, M.V. Gil Navarro & E. Suárez García. (2008) Tratamiento farmacológico de la hepatitis B. Farmacia Hospitalaria 32:4, pages 234-248.
Crossref
Crossref
Vincent Soriano, Massimo Puoti, Marion Peters, Yves Benhamou, Mark Sulkowski, Fabien Zoulim, Stefan Mauss & Juergen Rockstroh. (2008) Care of HIV patients with chronic hepatitis B: updated recommendations from the HIV-Hepatitis B Virus International Panel. AIDS 22:12, pages 1399-1410.
Crossref
Crossref
Vincent Soriano, Eugenia Vispo, Marcelle Bottecchia, Julie Sheldon, Paula Tuma, Javier Garcia-Samaniego & Pablo Barreiro. (2008) Management of hepatitis B virus co-infection on and off antiretroviral therapy. Current HIV/AIDS Reports 5:2, pages 86-93.
Crossref
Crossref
Silvia Gaia, Valeria Barbon, Antonina Smedile, Antonella Olivero, Silvia Carenzi, Marco Lagget, Carlo Alessandria, Mario Rizzetto & Alfredo Marzano. (2008) Lamivudine-resistant chronic hepatitis B: An observational study on adefovir in monotherapy or in combination with lamivudine. Journal of Hepatology 48:4, pages 540-547.
Crossref
Crossref
Marcelle Bottecchia, Javier Garcia-Samaniego & Vincent Soriano. (2008) The implications of antiviral drugs with activity against hepatitis B virus and HIV. Current Opinion in Internal Medicine 7:1, pages 57-64.
Crossref
Crossref
Thomas F. KresinaDiana SylvestreLeonard SeeffAlain H. LitwinKenneth HoffmanRobert LubranH. Westley Clark. (2008) Hepatitis Infection in the Treatment of Opioid Dependence and Abuse. Substance Abuse: Research and Treatment 1, pages SART.S580.
Crossref
Crossref
R. Morillo Verdugo, A. Madrazo Berenguer, M.V. Gil Navarro & E. Suárez García. (2008) Drugs Treatment of Hepatitis B. Farmacia Hospitalaria (English Edition) 32:4, pages 234-248.
Crossref
Crossref
Jia-Horng Kao. (2007) Role of viral factors in the natural course and therapy of chronic hepatitis B. Hepatology International 1:4, pages 415-430.
Crossref
Crossref